Abstract:The NAIP/NLRC4 inflammasome is classically associated with the detection of bacterial invasion to the cytosol. However, recent studies have demonstrated that NAIP/NLRC4 is also activated in non-bacterial infections, and in sterile inflammation. Moreover, in addition to the well-established model for the detection of bacterial proteins by NAIP proteins, the participation of other cytosolic pathways in the regulation of NAIP/NLRC4-mediated responses has been reported in distinct contexts. Using pharmacological inhibition and genetic deletion, we demonstrate here that cathepsins, well known for their involvement in NLRP3 activation, also regulate NAIP/NLRC4 responses to cytosolic flagellin in murine and human macrophages. In contrast to that observed for NLRP3 agonists, cathepsins inhibition did not reduce ASC speck formation or caspase-1 maturation in response to flagellin, ruling out their participation in the effector phase of NAIP/NLRC4 activation. Moreover, cathepsins had no impact on NF-κB-mediated priming of pro-IL-1β, thus suggesting these proteases act downstream of the NAIP/NLRC4 inflammasome activation. IL-1β levels secreted in response to flagellin were reduced in the absence of either cathepsins or Gasdermin-D (GSDMD), a molecule involved in the induction of pyroptosis and cytokines release. Notably, IL-1β secretion was abrogated in the absence of both GSDMD and cathepsins, demonstrating their non-redundant roles for the optimal IL-1β release in response to cytosolic flagellin. Given the central role of NAIP/NLRC4 inflammasomes in controlling infection and, also, induction of inflammatory pathologies, many efforts have been made to uncover novel molecules involved in their regulation. Thus, our findings bring together a relevant contribution by describing the role of cathepsins as players in the NAIP/NLRC4-mediated responses.

Β-Catenin Promotes NLRP3 Inflammasome Activation Via Increasing the Association Between NLRP3 and ASC

Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

Acetylation is required for NLRP3 self-aggregation and full activation of the inflammasome

NLRP3 Inflammasome: A key contributor to the inflammation formation

Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation

Cullin1 Binds and Promotes NLRP3 Ubiquitination to Repress Systematic Inflammasome Activation

Role of NLR family pyrin domain-containing 3 inflammasome in the activation of pancreatic stellate cells

Chicken Cathelicidin-2 Promotes NLRP3 Inflammasome Activation in Macrophages.

CCDC50 Suppresses NLRP3 Inflammasome Activity by Mediating Autophagic Degradation of NLRP3

Β-Arrestin1 is Critical for the Full Activation of NLRP3 and NLRC4 Inflammasomes

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Acetylation is required for full activation of the NLRP3 inflammasome

The transcriptomic landscape of canonical activation of NLRP3 inflammasome from bone marrow-derived macrophages

Lysosomal cathepsins act in concert with Gasdermin-D during NAIP/NLRC4-dependent IL-1β secretion

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

Research Progress in Mechanisms of NLRP3 Inflammasome Activation and Regulation

AKT Controls NLRP3 Inflammasome Activation by Inducing DDX3X Phosphorylation

NLRP3 Inflammasome: Activation, Regulation, and Role in Diseases

SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation.